{"pub": "washingtontimes", "url": "https://washingtontimes.com/news/2019/sep/4/drugmaker-mallinckrodt-settles-case-on-kickbacks-t", "downloaded_at": "2019-09-04 23:48:12.477825+00:00", "published_at": "2019-09-04", "title": "Drugmaker Mallinckrodt settles case on kickbacks to doctors", "language": "en", "text": "A drugmaker has agreed to pay $15.4 million to settle claims that a company it purchased lavished doctors with dinners and entertainment to encourage them to keep prescribing a drug as its price ballooned, under an agreement announced Wednesday by the U.S. Department of Justice.\n\nBritain-based Mallinckrodt resolved kickback claims that were spelled out in a court filing earlier this year in Philadelphia. The claims pertain to actions from 2009 to 2013 by Questcor Pharmaceuticals, a company Mallinckrodt has since bought.\n\n\u201cWhen companies buy off doctors, patients suffer,\u201d William McSwain, U.S. attorney for the Eastern District of Pennsylvania, said in a statement.\n\nThe government says the company raised the price of a roughly 5-dose vial of Acthar, a gel used to treat conditions related to multiple sclerosis, lupus and other diseases, from $50 to $32,000 from 2001 through 2014.\n\nThe company directed reporters to a statement from its general counsel, Mark Casey: \u201cWe are pleased to have conclusively resolved and put this Questcor matter behind us,\u201d he said. \u201cWhere we can resolve legacy legal matters in a reasonable and manageable way, we will continue to do so.\u201d\n\nThe deal does not resolve other claims by the government, also filed in June, alleging the company used a charity to subsidize Medicare patients\u2019 copayments for Acthar to allow it to keep raising prices.\n\nWhistleblowers are to receive nearly $3 million for their role in bringing the case to light.\n\nSign up for Daily Newsletters\n\nCopyright \u00a9 2019 The Washington Times, LLC.", "description": "A drugmaker has agreed to pay $15.4 million to settle claims that a company it purchased lavished doctors with dinners and entertainment to encourage them to keep prescribing a drug as its price ballooned, under an agreement announced Wednesday by the U.S. Department of Justice.", "authors": ["The Washington Times Http", "The Associated Press"], "top_image": ""}